Question 5

Allison and Honjo will continue testing immunotherapy as a treatment for cancer.

Given the promising results of immunotherapy in their research, it is logical to expect that James P. Allison and Tasuku Honjo will persist in exploring and testing this innovative treatment for cancer.

A) continue testing it as a treatment for cancer.

This option is correct as the extract emphasizes the groundbreaking efforts of Allison and Honjo in immunotherapy and their ongoing projects aimed at improving cancer treatment. Their significant contributions and the reinvestment in immunotherapy by research initiatives suggest a strong likelihood of continued testing.

B) retire soon from the medical community.

This option is incorrect because the extract highlights the active roles of both scientists in ongoing research efforts. There is no indication of impending retirement; instead, their work suggests a commitment to advancing cancer treatment.

C) write a book about their Nobel Peace Prize.

This option is incorrect as the extract does not mention any intentions of Allison and Honjo to write a book. Their focus appears to be on research rather than documenting their accomplishments in literary form.

D) focus on other treatments for cancer.

This option is incorrect as the extract specifically discusses their work in immunotherapy and the importance of this field. There is no indication that they will divert their attention to other types of cancer treatments, especially given the success of their current research.

Conclusion

Option A is definitively the correct choice as it aligns with the ongoing efforts of Allison and Honjo in the field of immunotherapy, which has shown promising results. The other options do not reflect their active engagement in cancer research and the implications of their recent findings, making them less plausible. Their commitment to continuing this innovative treatment is underscored by the significant financial backing it has received.